Topline

Zacks Small Cap Research – LGND: 2025 View Calls for 17% Topline Growth – Go Health Pro

by
Zacks Small Cap Research – LGND: 2025 View Calls for 17% Topline Growth – Go Health Pro

By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) held its annual analyst day on December 10th, 2024 in Boston. The company provided its 2025 expectations calling for topline revenues of $180 to $200 million and core adjusted earnings per share (EPS) of $6.00 to $6.25. This represents an … Read more

Zacks Small Cap Research – MDAI: December Topline Expected – Go Health Pro

by
Zacks Small Cap Research – MDAI: December Topline Expected – Go Health Pro

By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported third quarter results on November 6th, 2024. Revenues totaled $8.2 million and the burn trial has completed enrollment while the emergency department burn enrollment continues. The company also received additional funding from the Medical Technology Enterprise Consortium (MTEC) to … Read more

x